Oireachtas Joint and Select Committees
Wednesday, 12 July 2017
Joint Oireachtas Committee on Health
Evaluating Orphan Drugs: Discussion
9:00 am
Professor Michael Barry:
To be assured of meeting the timelines. For me, quality is probably important as well. As I always tell the industry, it is important to have quality people assessing its dossiers, in that it leads to a better outcome and the work is done properly. We have managed to keep to the timelines as much as possible.